One-way sensitivity analysis of hypertension treatment inputs. by Dongfeng Gu (216367)

Subjects:

Male circumcision (MC) prevalence before start of voluntary medical male circumcision (VMMC) program and unadjusted modeled MC prevalence by end 2016 for Homa Bay, Kisumu, Migori,... by Katharine Kripke (559963)

Subjects:

Demographic characteristics of IDI participants, Upper East region 2017. by Evelyn Sakeah (835769)

Subjects:

HIV infections averted in Homa Bay, Kisumu, Migori, and Siaya, 2008–2020. by Katharine Kripke (559963)

Subjects:

Data collected. by Evelyn Sakeah (835769)

Subjects:

CVD Policy Model-China structure. by Dongfeng Gu (216367)

Subjects:

An overview of themes and subthemes from twitter data in the U.S., Brazil, and India. by Emmanuel A. Odame (21369250)

Subjects:

Demographic characteristics of FGD participants, Upper East region 2017. by Evelyn Sakeah (835769)

Subjects:

Main assumptions for the cost-effectiveness analysis of China hypertension control policy. by Dongfeng Gu (216367)

Subjects:

Data triangulation to estimate age-specific coverage of voluntary medical male circumcision for HIV prevention in four Kenyan counties by Katharine Kripke (559963)

Subjects:

Male circumcision (MC) prevalence before start of voluntary medical male circumcision (VMMC) program, unadjusted modeled MC prevalence by end 2016, and adjusted modeled MC prevalen... by Katharine Kripke (559963)

Subjects:

The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study by Dongfeng Gu (216367)

Subjects:

Study inclusion and exclusion criteria. by Emmanuel A. Odame (21369250)

Subjects:

Cost-effectiveness acceptability curves comparing treating all untreated hypertensive adults (blue) with treating only untreated CVD patients and adults with stage 2 hypertension b... by Dongfeng Gu (216367)

Subjects:

Male circumcision (MC) prevalence before start of voluntary medical male circumcision (VMMC) program, unadjusted modeled MC prevalence by end 2016, and adjusted modeled MC prevalen... by Katharine Kripke (559963)

Subjects:

Keywords and their explanations. by Emmanuel A. Odame (21369250)

Subjects:

Effectiveness and cost-effectiveness of implementing different BP control guidelines in untreated Chinese adults aged 35–84 y with hypertension, averaged from the projections for 2... by Dongfeng Gu (216367)

Subjects:

Inclusion and exclusion criteria for systematic review. by Warda Javed (15389332)

Subjects:

Outline of the Vaccine Champions program in Tonga. by Yasmin Mohamed (4032353)

Subjects:

Community attendees’ support for vaccines after attending a Vaccine Champion information session. by Yasmin Mohamed (4032353)

Subjects: